Osteoglycin as a Potential Biomarker of Mild Kidney Function Impairment in Type 2 Diabetes Patients

Osteoglycin (OGN) could be a biomarker of mild kidney function impairment in type 2 diabetes (T2D). Our study aimed to determine the association between serum OGN and impaired kidney function risk in T2D patients and to analyze its potential role as an estimator of kidney disturbances in this popula...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Salvatierra, Sheila, García-Fontana, Cristina, Andújar-Vera, Francisco, Grau-Perales, Alejandro Borja, Martínez-Heredia, Luis, Avilés-Pérez, María Dolores, Hayón-Ponce, María, Iglesias-Baena, Iván, Riquelme-Gallego, Blanca, Muñoz-Torres, Manuel, García-Fontana, Beatriz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161135/
https://www.ncbi.nlm.nih.gov/pubmed/34065223
http://dx.doi.org/10.3390/jcm10102209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161135/
https://www.ncbi.nlm.nih.gov/pubmed/34065223
http://dx.doi.org/10.3390/jcm10102209

Ejemplares similares